AMAM — AMBRX BIOPHARMA INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
HoldingsHub 追踪了 AMAM(AMBRX BIOPHARMA INC)近五年的季度 13F 申报数据。历史上有 81 家基金申报过持仓,其最近一期申报市值合计 $920.25M。最新季度无机构披露持仓,通常意味着该股已退出追踪基金的组合,而非不可投资。
AMBRX BIOPHARMA INC(AMAM)的主要机构持有人包括 Darwin Global Management, Ltd.、Cormorant Asset Management, LP、D. E. Shaw & Co., Inc.,按 13F 申报市值在本页 81 家持有人中排名居前。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q4 2023 | 65 | 58.48M | $817.29M | +4.8% |
| Q3 2023 | 50 | 50.15M | $572.87M | -13.1% |
| Q2 2023 | 14 | 11.42M | $172.76M | +35.1% |
| Q1 2023 | 10 | 7.94M | $68.69M | +23.3% |
| Q4 2022 | 6 | 2.80M | $6.30M | -26.2% |
| Q3 2022 | 6 | 3.79M | $4.09M | -5.0% |
| Q2 2022 | 5 | 3.97M | $10.53M | +0.5% |
| Q1 2022 | 5 | 3.96M | $16.30M | -0.3% |
表内 8 个季度中,机构持股合计增加 1378%(Q1 2022 → Q4 2023);单季变动最大的是 Q2 2023(+35.1%)。
前 25 大机构持仓人(Q4 2023) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 16.69M | $237.65M | 46.65% | 持有 | |
| 11.23M | $159.93M | 7.64% | 增持 | |
| 4.24M | $60.38M | 0.21% | 增持 | |
| 4.24M | $60.38M | 0.06% | 增持 | |
| 3.71M | $52.84M | 1.84% | 新进 | |
| 2.15M | $30.68M | 0.12% | 新进 | |
| 2.10M | $29.90M | 3.06% | 增持 | |
| 2.07M | $29.48M | 2.02% | 持有 | |
| 1.47M | $20.99M | 0.00% | 减持 | |
| 1.40M | $19.93M | 0.00% | 新进 | |
| 1.26M | $17.87M | 0.20% | 新进 | |
| 1.08M | $15.44M | 0.00% | 增持 | |
| 432.71K | $6.16M | 0.01% | 增持 | |
| 432.71K | $6.16M | 0.00% | 减持 | |
| 399.65K | $5.69M | 0.00% | 新进 | |
| 385.38K | $5.49M | 3.27% | 增持 | |
| 330.95K | $4.71M | 0.01% | 减持 | |
| 300.00K | $4.27M | 0.01% | 增持 | |
| 296.00K | $4.22M | 0.08% | 新进 | |
| 295.64K | $4.21M | 0.01% | 新进 | |
| 263.74K | $3.76M | 0.04% | 新进 | |
| 258.36K | $3.68M | 0.00% | 增持 | |
| 207.50K | $2.95M | 0.52% | 增持 | |
| 203.12K | $2.89M | 1.05% | 增持 | |
| 199.95K | $2.85M | 0.01% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q3 2023 — 25 家基金
Q2 2023 — 14 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.02M | $66.10M | 0.07% | 增持 | |
| 2.27M | $37.35M | 0.21% | 增持 | |
| 2.21M | $36.39M | 0.00% | 持有 | |
| 863.52K | $14.21M | 0.00% | 减持 | |
| 349.94K | $5.76M | 0.03% | 新进 | |
| 285.72K | $4.70M | 0.00% | 增持 | |
| 157.86K | $2.60M | 0.00% | 新进 | |
| 144.40K | $2.38M | 0.04% | 新进 | |
| 95.40K | $1.57M | 0.00% | 减持 | |
| 59.20K | $973.79K | 0.00% | 增持 | |
| 39.44K | $649.15K | 0.00% | 新进 | |
| 3.07K | $50.53K | 0.00% | 增持 | |
| 929.32K | $15.30K | 0.00% | 增持 | |
| 558 | $9.19K | 0.00% | 增持 |
Q1 2023 — 10 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.93M | $35.09M | 0.04% | 新进 | |
| 2.21M | $19.72M | 0.00% | 减持 | |
| 910.03K | $8.12M | 0.00% | 增持 | |
| 361.00K | $3.22M | 0.02% | 新进 | |
| 255.67K | $2.28M | 0.00% | 增持 | |
| 29.52K | $262.16K | 0.00% | 新进 | |
| 210.63K | $1.88K | 0.00% | 新进 | |
| 104 | $928 | 0.00% | 增持 | |
| 42 | $375 | 0.00% | 新进 | |
| 30.99K | $276 | 0.00% | 增持 |
Q4 2022 — 6 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 2.70M | $6.12M | 0.00% | 减持 | |
| 44.66K | $101.39K | 0.00% | 增持 | |
| 32.50K | $74.00K | 0.00% | 减持 | |
| 3.04K | $6.91K | 0.00% | 减持 | |
| 100 | $227 | 0.00% | 减持 | |
| 18.79K | $43 | 0.00% | 减持 |
Q3 2022 — 6 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 3.59M | $3.88M | 0.00% | 减持 | |
| 113.69K | $123.00K | 0.00% | 增持 | |
| 64.00K | $69.00K | 0.00% | 增持 | |
| 12.12K | $13.00K | 0.00% | 新进 | |
| 7.97K | $9.00K | 0.00% | 增持 | |
| 101 | $0 | — | 持有 |
新建仓(最新)
本季度没有基金新建该仓位。
完全清仓(较上季)
本季度没有被追踪基金完全清仓。
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | 16.69M | 16.69M | — | — | — | — | — | — | — | — |
| Cormorant Asset Management, LP | 11.23M | 9.92M | — | — | — | — | — | — | — | — |
| D. E. Shaw & Co., Inc. | 4.24M | 4.00M | — | — | — | — | — | — | — | — |
| D. E. Shaw & Co | 4.24M | 4.00M | 4.02M | 3.93M | — | — | — | — | — | — |
| Deep Track Capital, LP | 3.71M | — | — | — | — | — | — | — | — | — |
| Balyasny Asset Management | 2.15M | — | — | — | — | — | — | — | — | — |
| Logos Global Management LP | 2.10M | 115.00K | — | — | — | — | — | — | — | — |
| Venrock Adviser, LLC | 2.07M | 2.07M | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 1.47M | 1.76M | 2.21M | 2.21M | 2.70M | 3.59M | 3.86M | 3.83M | 3.86M | 3.86M |
| Vanguard Group | 1.40M | — | — | — | — | — | — | — | — | — |
| Woodline Partners LP | 1.26M | — | — | — | — | — | — | — | — | — |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.08M | 821.56K | — | — | — | — | — | — | — | — |
| MILLENNIUM MANAGEMENT LLC | 432.71K | 30.00K | — | — | — | — | — | — | — | — |
| Millennium Management | 432.71K | 606.93K | 285.72K | 30.99K | 18.79K | 113.69K | 102.78K | 104.43K | 98.42K | 141.43K |
| Goldman Sachs Group | 399.65K | — | — | — | — | — | — | — | — | — |
| Ally Bridge Group (NY) LLC | 385.38K | 281.09K | — | — | — | — | — | — | — | — |
| FEDERATED HERMES, INC. | 330.95K | 2.40M | — | — | — | — | — | — | — | — |
| MACQUARIE GROUP LTD | 300.00K | 250.00K | — | — | — | — | — | — | — | — |
| ORBIMED ADVISORS LLC | 296.00K | — | — | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 295.64K | — | — | — | — | — | — | — | — | — |
常见问题
Which funds hold AMAM?
81 funds have reported positions in AMAM across five years of 13F filings; the sum of their latest reported stakes is $920.25M.
Who are the top institutional holders of AMAM?
The largest 13F holders are Darwin Global Management, Ltd., Cormorant Asset Management, LP, D. E. Shaw & Co., Inc., D. E. Shaw & Co, Deep Track Capital, LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of AMBRX BIOPHARMA INC?
The major shareholders of AMBRX BIOPHARMA INC (AMAM) by reported 13F value are Darwin Global Management, Ltd., Cormorant Asset Management, LP, D. E. Shaw & Co., Inc., D. E. Shaw & Co, Deep Track Capital, LP, among 81 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.